Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Saved in:
| Title: | Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. |
|---|---|
| Authors: | Keystone E (AUTHOR), van der Heijde D (AUTHOR), Mason D Jr. (AUTHOR), Landewé R (AUTHOR), van Vollenhoven R (AUTHOR), Combe B (AUTHOR), Emery P (AUTHOR), Strand V (AUTHOR), Mease P (AUTHOR), Desai C (AUTHOR), Pavelka K (AUTHOR) |
| Source: | Arthritis & Rheumatism. Nov2008, Vol. 58 Issue 11, p3319-3329. 11p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 105581760 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Keystone+E%22">Keystone E</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+der+Heijde+D%22">van der Heijde D</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mason+D+Jr%2E%22">Mason D Jr.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Landewé+R%22">Landewé R</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Vollenhoven+R%22">van Vollenhoven R</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Combe+B%22">Combe B</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Emery+P%22">Emery P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Strand+V%22">Strand V</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mease+P%22">Mease P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Desai+C%22">Desai C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pavelka+K%22">Pavelka K</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Arthritis+%26+Rheumatism%22">Arthritis & Rheumatism</searchLink>. Nov2008, Vol. 58 Issue 11, p3319-3329. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=105581760 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/art.23964 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 3319 Titles: – TitleFull: Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Keystone E – PersonEntity: Name: NameFull: van der Heijde D – PersonEntity: Name: NameFull: Mason D Jr. – PersonEntity: Name: NameFull: Landewé R – PersonEntity: Name: NameFull: van Vollenhoven R – PersonEntity: Name: NameFull: Combe B – PersonEntity: Name: NameFull: Emery P – PersonEntity: Name: NameFull: Strand V – PersonEntity: Name: NameFull: Mease P – PersonEntity: Name: NameFull: Desai C – PersonEntity: Name: NameFull: Pavelka K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2008 Type: published Y: 2008 Identifiers: – Type: issn-print Value: 00043591 Numbering: – Type: volume Value: 58 – Type: issue Value: 11 Titles: – TitleFull: Arthritis & Rheumatism Type: main |
| ResultId | 1 |
